Richard K. Prins - 19 Jan 2026 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
/s/ Richard Prins
Issuer symbol
IGC
Transactions as of
19 Jan 2026
Net transactions value
$0
Form type
4
Filing time
20 Jan 2026, 16:01:43 UTC
Previous filing
25 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PRINS RICHARD K Director 10224 FALLS ROAD, POTOMAC /s/ Richard Prins 20 Jan 2026 0001047579

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGC Common Stock Options Exercise $0 +100,000 +7.9% $0.000000 1,371,251 19 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Restricted Stock Units Options Exercise $0 -100,000 -67% $0.000000 50,000 19 Jan 2026 Common Stock 100,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
F2 Each restricted stock unit represents a right to receive one share of IGC common stock.